Cathie Wood's ARK ETF trades Shopify, Toast stock amid tech focus

Cathie Wood's ARK ETFs executed significant trades on June 24, 2025, primarily accumulating positions in technology and genomics firms. The largest acquisitions included a $3.72 million investment in Shopify (SHOP) across ARKK, ARKW, and ARKF, signaling a continued bullish stance, alongside a $3.03 million purchase of Toast (TOST) and $2.56 million in Airbnb (ABNB). ARK also increased holdings in BWX Technologies (BWXT) and Illumina (ILMN), consistent with its strategy of investing in innovative growth companies. Minor divestments were noted in Adaptive Biotechnologies (ADPT), Magna (MGA), and UiPath (PATH).

Analysis

ARK Invest's trading activity on June 24, 2025, demonstrates a focused and continued accumulation of high-conviction technology and genomics stocks. The firm deployed significant capital into several key names, most notably a $3.72 million purchase of Shopify (SHOP) and a $3.03 million investment in Toast (TOST), signaling a strong bullish outlook on e-commerce and restaurant tech platforms. This pattern of strategic accumulation is also evident in the $2.56 million acquisition of Airbnb (ABNB) and a $1.28 million buy of BWX Technologies (BWXT), both of which follow a series of recent purchases in the respective stocks. The firm's commitment to the genomics sector was reinforced by a $2.57 million investment in Illumina (ILMN) and smaller, yet consistent, buys across a basket of related companies including BEAM, CRSP, and NTLA. In contrast, selling activity was minimal, highlighted by a continued, albeit small, divestment from Adaptive Biotechnologies (ADPT) for $104,955 and negligible sales in Magna (MGA) and UiPath (PATH). This disparity between substantial, repeated buying and minor selling underscores a clear strategy of concentrating capital in disruptive growth assets while trimming fringe positions.

Key Decisions for Investors

• Investors should note the high-conviction, multi-day accumulation in Shopify (SHOP), Toast (TOST), and Airbnb (ABNB) as a strong bullish signal from ARK, warranting a closer look at these names for those aligned with a long-term disruptive growth thesis.
• The consistent buying across a portfolio of genomics stocks, led by Illumina (ILMN), suggests a sector-wide positive view; consider evaluating the broader genomics theme for portfolio allocation rather than focusing on a single stock's daily move.
• The continued selling of Adaptive Biotechnologies (ADPT), even in small tranches, should be treated as a persistent bearish indicator from ARK on that specific company, prompting current holders to reassess their position.
• Given the strategy of building positions over time, these trades are best viewed as a directional indicator; long-term investors should monitor the trend and total size of ARK's holdings in these key companies rather than reacting to a single day of trading flows.